Vivo Capital »

Sensei Biotherapeutics shares owned by Vivo Capital

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $23M 722k 31.52

More positions owned by Vivo Capital

Erasca Common (ERAS)
Praxis Precision Medicines Common (PRAX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
DBV Technologies SA Sponsored Ads (DBVT)
Compass Therapeutics Common (CMPX)
Tango Therapeutics Common (TNGX)
SAB Biotherapeutics Common (SABS)
Corvus Pharmaceuticals Holdings Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Dianthus Therapeutics Common (DNTH)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Minerva Neurosciences Common (NERV)

View all positions for Vivo Capital

Top funds holding Sensei Biotherapeutics

Vivo Capital
Cormorant Asset Management
Millennium Management
Franklin Resources
Stempoint Capital
Trails Edge Capital Partners
Goldman Sachs Group
Hrt Financial
Suvretta Capital Management
Bank of America Corporation
Logos Global Management
Boothbay Fund Management
Brevan Howard Capital Management
Fred Alger Management
Balyasny Asset Management

View all funds holding Sensei Biotherapeutics